2020-05-27T16:02:01Z
2020-05-28T05:10:23Z
2019-11-09
2020-05-27T16:02:02Z
Mycobacterial infection-related morbidity and mortality in patients following cardiopulmonary bypass surgery is high and there is a growing need for a consensus-based expert opinion to provide international guidance for diagnosing, preventing and treating in these patients. In this document the International Society for Cardiovascular Infectious Diseases (ISCVID) covers aspects of prevention (field of hospital epidemiology), clinical management (infectious disease specialists, cardiac surgeons, ophthalmologists, others), laboratory diagnostics (microbiologists, molecular diagnostics), device management (perfusionists, cardiac surgeons) and public health aspects.
Artículo
Versión publicada
Inglés
Malalties cardiovasculars; Infeccions; Derivació cardiopulmonar; Cardiovascular diseases; Infections; Cardiopulmonary bypass
Elsevier
Reproducció del document publicat a: https://doi.org/10.1016/j.jhin.2019.10.009
Journal of Hospital Infection, 2019, vol. 104, num. 2, p. 214-235
https://doi.org/10.1016/j.jhin.2019.10.009
cc-by-nc-nd (c) Hasse et al., 2019
http://creativecommons.org/licenses/by-nc-nd/3.0/es